These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 22310721)
1. Comparative autoantibody profiling before and after appearance of malignance: identification of anti-cathepsin D autoantibody as a promising diagnostic marker for lung cancer. Luo X; Lu F; Wang HL; Wang N; Li WH; Guo N; Wang HX; Xia Q Biochem Biophys Res Commun; 2012 Apr; 420(4):704-9. PubMed ID: 22310721 [TBL] [Abstract][Full Text] [Related]
2. Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma. Fujita Y; Nakanishi T; Miyamoto Y; Hiramatsu M; Mabuchi H; Miyamoto A; Shimizu A; Takubo T; Tanigawa N Cancer Lett; 2008 May; 263(2):280-90. PubMed ID: 18334280 [TBL] [Abstract][Full Text] [Related]
3. [Proteome analysis of autoantibodies in sera of patients with cancer]. Ueda K Rinsho Byori; 2005 May; 53(5):437-45. PubMed ID: 15966408 [TBL] [Abstract][Full Text] [Related]
4. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma. Fujita Y; Nakanishi T; Hiramatsu M; Mabuchi H; Miyamoto Y; Miyamoto A; Shimizu A; Tanigawa N Clin Cancer Res; 2006 Nov; 12(21):6415-20. PubMed ID: 17085654 [TBL] [Abstract][Full Text] [Related]
5. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596 [TBL] [Abstract][Full Text] [Related]
6. Identification of an anti-aldolase autoantibody as a diagnostic marker for diabetic retinopathy by immunoproteomic analysis. Ahn BY; Song ES; Cho YJ; Kwon OW; Kim JK; Lee NG Proteomics; 2006 Feb; 6(4):1200-9. PubMed ID: 16421937 [TBL] [Abstract][Full Text] [Related]
7. Cathepsin D is secreted from M-BE cells: its potential role as a biomarker of lung cancer. Lou X; Xiao T; Zhao K; Wang H; Zheng H; Lin D; Lu Y; Gao Y; Cheng S; Liu S; Xu N J Proteome Res; 2007 Mar; 6(3):1083-92. PubMed ID: 17284061 [TBL] [Abstract][Full Text] [Related]
8. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer. Hong SH; Misek DE; Wang H; Puravs E; Giordano TJ; Greenson JK; Brenner DE; Simeone DM; Logsdon CD; Hanash SM Cancer Res; 2004 Aug; 64(15):5504-10. PubMed ID: 15289361 [TBL] [Abstract][Full Text] [Related]
9. Dickkopf-1 autoantibody is a novel serological biomarker for non-small cell lung cancer. Yao X; Jiang H; Zhang C; Wang H; Yang L; Yu Y; Yu J; Shi B; Shen Z; Gao H; Chen Z; Tian S; Lu S; Li Z; Gu J Biomarkers; 2010 Mar; 15(2):128-34. PubMed ID: 19839718 [TBL] [Abstract][Full Text] [Related]
10. Anti-alpha-enolase autoantibodies are down-regulated in advanced cancer patients. Shih NY; Lai HL; Chang GC; Lin HC; Wu YC; Liu JM; Liu KJ; Tseng SW Jpn J Clin Oncol; 2010 Jul; 40(7):663-9. PubMed ID: 20395242 [TBL] [Abstract][Full Text] [Related]
11. Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysis. Tamesa MS; Kuramitsu Y; Fujimoto M; Maeda N; Nagashima Y; Tanaka T; Yamamoto S; Oka M; Nakamura K Electrophoresis; 2009 Jun; 30(12):2168-81. PubMed ID: 19582718 [TBL] [Abstract][Full Text] [Related]
12. Humoral immune responses to cathepsin D and glucose-regulated protein 78 in ovarian cancer patients. Chinni SR; Falchetto R; Gercel-Taylor C; Shabanowitz J; Hunt DF; Taylor DD Clin Cancer Res; 1997 Sep; 3(9):1557-64. PubMed ID: 9815843 [TBL] [Abstract][Full Text] [Related]
13. Development of a "reverse capture" autoantibody microarray for studies of antigen-autoantibody profiling. Qin S; Qiu W; Ehrlich JR; Ferdinand AS; Richie JP; O'leary MP; Lee ML; Liu BC Proteomics; 2006 May; 6(10):3199-209. PubMed ID: 16596707 [TBL] [Abstract][Full Text] [Related]
14. Development of autoantibody signatures as novel diagnostic biomarkers of non-small cell lung cancer. Wu L; Chang W; Zhao J; Yu Y; Tan X; Su T; Zhao L; Huang S; Liu S; Cao G Clin Cancer Res; 2010 Jul; 16(14):3760-8. PubMed ID: 20501620 [TBL] [Abstract][Full Text] [Related]
15. Epitope recognition by anti-cathepsin D autoantibodies in endometrial cancer patients. Bosscher JR; Gerçel-Taylor C; Watkins CS; Taylor DD Gynecol Oncol; 2001 May; 81(2):138-43. PubMed ID: 11330940 [TBL] [Abstract][Full Text] [Related]
16. Serum-autoantibodies for discovery of prostate cancer specific biomarkers. Massoner P; Lueking A; Goehler H; Höpfner A; Kowald A; Kugler KG; Amersdorfer P; Horninger W; Bartsch G; Schulz-Knappe P; Klocker H Prostate; 2012 Mar; 72(4):427-36. PubMed ID: 22012634 [TBL] [Abstract][Full Text] [Related]
17. Autoantibodies against tumor-associated antigens in the early detection of lung cancer. Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936 [TBL] [Abstract][Full Text] [Related]
18. [Autoantibodies against tumor-related antigens: new tools for early detection of lung cancer]. Solassol J; Harmand PO; Maudelonde T; Pujol JL Bull Cancer; 2011 Dec; 98(12):1419-30. PubMed ID: 22146366 [TBL] [Abstract][Full Text] [Related]
19. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis. Yi JK; Chang JW; Han W; Lee JW; Ko E; Kim DH; Bae JY; Yu J; Lee C; Yu MH; Noh DY Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1357-64. PubMed ID: 19423516 [TBL] [Abstract][Full Text] [Related]
20. Anti-tumor and anti-ovarian autoantibodies in women with ovarian cancer. Barua A; Bradaric MJ; Kebede T; Espionosa S; Edassery SL; Bitterman P; Rotmensch J; Luborsky JL Am J Reprod Immunol; 2007 Apr; 57(4):243-9. PubMed ID: 17362385 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]